The management of Helicobacter pylori infection in primary care:: a systematic review of the literature

被引:4
作者
Childs, SM [1 ]
Roberts, AP [1 ]
Meineche-Schmidt, V [1 ]
de Wit, NJ [1 ]
Rubin, GP [1 ]
机构
[1] Univ Durham, Ctr Hlth Studies, Durham DH1 3HN, England
关键词
dyspepsia; Helicobacter pylori; peptic ulcer; literature review; stomach neoplasms;
D O I
10.1093/fampra/17.suppl_2.S6
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective. The aim of the present study was to provide evidence from the literature to inform the production of guidelines by the European Society for Primary Care Gastroenterology (ESPCG) for the management of Helicobacter pylori infection in primary care. Methods. A systematic review was conducted, searching MEDLINE, EM BASE and the Cochrane Library. The systematic review was designed to answer a number of questions: the role of H.pylori in the aetiology of peptic ulcer disease (PUD), gastric cancer (GC), non-ulcer dyspepsia (NUD) and oesophagitis; non-invasive testing for H.pylori and post-treatment testing; eradication therapy; and cost issues. Selection of records concentrated on the highest quality studies, i.e. systematic reviews, meta-analyses and cost analyses. Results. Helicobacter pylori infection is a causal factor in PUD and GC but not in NUD or oesophagitis. Serological tests and urea breath tests (UBTs) can be used for the detection of H.pylori, but UBT is the preferred choice for post-treatment testing. Proton pump inhibitor (PPI)based triple regimens are the preferred eradication therapy. Eradication therapy is more cost-effective than long-term maintenance therapy. Conclusions. Strong evidence is available for answering questions on the aetiology of stomach ulcers and GU, eradication therapies and cost issues. Weaker evidence is available for answering the questions on the aetiology of NUD and non-invasive testing. No evidence is available for answering the question on the role of H.pylori in the aetiology of oesophagitis.
引用
收藏
页码:S6 / S11
页数:6
相关论文
共 59 条
[1]   Efficacy of lansoprazole in eradicating Helicobacter pylori: A meta-analysis [J].
Bazzoli, F ;
Pozzato, P ;
Zagari, M ;
Fossi, S ;
Ricciardiello, L ;
Nicolini, G ;
Berretti, D ;
De Luca, L .
HELICOBACTER, 1998, 3 (03) :195-201
[2]   Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age [J].
Briggs, AH ;
Sculpher, MJ ;
Logan, RPH ;
Aldous, J ;
Ramsay, ME ;
Baron, JH .
BRITISH MEDICAL JOURNAL, 1996, 312 (7042) :1321-1325
[3]  
Burette A, 1998, ACTA GASTRO-ENT BELG, V61, P336
[4]   Discontinuation rates of Helicobacter pylori treatment regimens:: A meta-analysis [J].
Buring, SM ;
Winner, LH ;
Hatton, RC ;
Doering, PL .
PHARMACOTHERAPY, 1999, 19 (03) :324-332
[5]  
Chiba N, 1998, CAN FAM PHYSICIAN, V44, P1481
[6]  
CHIBA N, 1992, AM J GASTROENTEROL, V87, P1716
[7]  
DELANEY BC, 1995, BRIT J GEN PRACT, V45, P489
[8]  
Deltenre MAL, 1997, EUR J GASTROEN HEPAT, V9, pS23
[9]  
Dobrucali A, 1998, Wien Med Wochenschr, V148, P464
[10]  
Ebell MH, 1997, J FAM PRACTICE, V44, P545